Clinical Trial Update: Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)

View source ↗

Summary

Clinical trial update on the kinetics of transmural healing in Crohn's disease patients treated with risankizumab (Skyrizi); the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Crohn Disease (CD), Transmural Response | Status: RECRUITING